Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System Between the Announcement of the Diagnosis and the First Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Central Nervous System Cancer
- Sponsor
- Centre Hospitalier Universitaire de la Réunion
- Enrollment
- 58
- Locations
- 1
- Primary Endpoint
- Distress thermometer
- Status
- Not yet recruiting
- Last Updated
- 3 months ago
Overview
Brief Summary
The goal of this clinal trial is to compare the effectiveness of nurse-led teleconsultation with usual care (intervention group) on psychological distress in patients with primary malignant tumors of the central nervous system between diagnosis and first anti-cancer treatment, versus usual care alone (control group).
Participants will be randomized into two groups :
- group A) intervention: usual care + nurse teleconsultation for psychological support
- group B) control: usual care alone
Enrolment = Day0 (D0)
Participants will :
- groups A and B: D0: complete 4 questionnaires (Quality of Life, Screening for Distress, Screening for Anxiety and Depression, Social Support Questionnaire)
- Group A : D0+2/4 das : nursing teleconsultation for psychological support
- Groups A and B: D0+10days : telephone call to complete the same 4 questionnaires as at inclusion
- Group A : D0+15days: semi-directive interview, at home, for voluntary patients.
Detailed Description
The expected benefits are as follows: For the patient : * Reduction in pre-treatment psychological distress * Reduced pre-treatment anxiety and depression * Better understanding of disease and treatments * Better adherence to the care proposed in the treatment pathway * Reduced stress during first hospital treatment For healthcare professionals : * Early detection of psychological distress * Early detection of unmet needs and appropriate individualized responses * Establishment of a climate of trust between patient and caregiver * Improved professional practices For the healthcare system : * Lower healthcare costs (fewer anxiolytic treatments, etc.) * Therapy to be integrated into the treatment pathway of patients with central nervous system cancer * Reduced socio-territorial inequalities in healthcare provision
Investigators
Eligibility Criteria
Inclusion Criteria
- •aged 18 and over
- •being treated for a primary malignant tumor of the central nervous system (positive biopsy)
- •with a Mini-Mental State score greater than 24
- •not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery)
- •with a distress score above 3 on the Psychological Distress Thermometer
- •have access to computer equipment equipped with a microphone and webcam (smartphone, computer)
- •able to read, write and speak French
- •have given free and informed consent
- •being affiliated to a social security scheme
Exclusion Criteria
- •with a history of psychiatric illness
- •with recurrent cancer of the cerebral nervous system
- •having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care)
- •under guardianship, curatorship or deprived of liberty
Outcomes
Primary Outcomes
Distress thermometer
Time Frame: 10 days
Comparison of the change in psychological distress score, measured using the psychological distress screening tool (from National Comprehensive Cancer Network) between the 2 groups between inclusion (T0) and before the first anti-cancer therapy (T1).